News & Updates
Filter by Specialty:

Can extended duration tinzaparin improve survival in CRC?
Extended duration perioperative thromboprophylaxis with low molecular weight heparin tinzaparin (administered before and for 56 days after surgery) does not lead to longer disease-free survival at 3 years in patients with localized invasive colorectal cancer undergoing surgical resection, reports a study.
Can extended duration tinzaparin improve survival in CRC?
20 Sep 2022
Trichomoniasis infection ups prostate cancer, benign prostate hyperplasia risk
Men with Trichomoniasis vaginalis infections appear to be at an elevated risk of prostate cancer (PCa) and benign prostate hyperplasia (BPH), according to a recent study.
Trichomoniasis infection ups prostate cancer, benign prostate hyperplasia risk
20 Sep 2022
PDE5-I use poses no excess cardiovascular, mortality risk in diabetic men with ED
The presence of erectile dysfunction (ED) does not appear to confer an increased risk of cardiovascular disease (CVD) and mortality in men with diabetes mellitus (DM), with comparable risk of adverse cardiovascular events among users and nonusers of phosphodiesterase-5 inhibitors (PDE5-Is), which are used to manage ED, according to a study.
PDE5-I use poses no excess cardiovascular, mortality risk in diabetic men with ED
20 Sep 2022
Daytime eating helps combat anxiety, depression among night shift workers
Among individuals who work at night, taking meals during the day appears to minimize the chances of experiencing mood symptoms related to anxiety and depression, as reported in a recent study.